NOUGUES MAXIMO F — SEC Form 4 filings
SEC reporting owner CIK 1758507. 9 Form 4 filings on record with FilingPulse; latest filed 2026-07-08.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-02-14 to 2026-07-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 8 legs across 6 filings — 49,531 shares, $240,313 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
- Largest priced transaction: sale of 9,386 shares @ $8.26 ($77,557) in PUMA BIOTECHNOLOGY, INC., filed 2026-07-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | Chief Financial Officer | 9 | — | 8 legs · 49,531 sh · $240,313 | 6 |
Form 4 filings — NOUGUES MAXIMO F
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-08 | 4 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Sale (S): 9,386 @ $8.26 | EDGAR |
| 2026-02-20 | 4 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Grant/award (A): 46,739 @ $0 · Grant/award (A): 66,541 (derivative) @ $0 | EDGAR |
| 2026-01-08 | 4 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Sale (S): 4,540 @ $5.84 · Sale (S): 6,405 @ $5.88 | EDGAR |
| 2025-07-10 | 4 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Sale (S): 5,587 @ $3.53 · Sale (S): 3,935 @ $3.54 | EDGAR |
| 2025-02-11 | 4 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Grant/award (A): 61,456 @ $0 · Grant/award (A): 85,067 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Sale (S): 10,227 @ $3.15 | EDGAR |
| 2024-07-18 | 4 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Sale (S): 4,156 @ $3.70 | EDGAR |
| 2024-07-02 | 4 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Sale (S): 5,295 @ $3.27 | EDGAR |
| 2024-02-14 | 4 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Grant/award (A): 43,307 @ $0 · Grant/award (A): 59,946 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1758507 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →